<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport Designated as Exclusive Cryogenic Logistics Provider to Triangle Research Labs

December 29, 2014

Lake Forest, CA, December 29, 2014 - Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for life sciences, announced today that it has entered into an agreement with Triangle Research Labs, LLC (“TRL”).  Under the agreement, Cryoport becomes the exclusive cryogenic logistics provider for TRL, providing it with the ability to support its overall demand growth and meet its ever-increasing demand for same day cryogenic shipping.

Read More


Tags: Press Releases, News, Dry Shipper, Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Triangle Research Labs, hepatocyte

Cryoport Increases Revenue by 65% for the First Six Months of Fiscal 2015

November 12, 2014

LAKE FOREST, CA – November 12, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for its second quarter and six months ended September 30, 2014.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Revenue, fiscal 2015

Cryoport & UPS Collaborate on Cryogenic Logistics Solutions for the Healthcare Industry

November 3, 2014

Lake Forest, CA, November 3, 2014 - Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that it is collaborating with UPS to enhance its temperature-sensitive shipping offerings to the healthcare industry.

Read More


Tags: Press Releases, News, Dry Shipper, Frozen Shipping, Frozen Shipping, frozen shipping solution, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, UPS

Cryoport Begins Delivering Novel Cryogenically Preserved Knee OA Treatment to Orthopedists

October 14, 2014

Lake Forest, CA (October 14, 2014) - Cryoport, Inc. (OTC:CYRX) announced today the first phase of deploying its “Regenerative Medicine Point-of-Care Repository Solution” for Liventa Bioscience’s introduction of Liventa’s AmnioClear® LCT therapy to orthopedic clinics in the US. More than 70 orthopedic clinics have expressed interest in the therapy. Of these clinics, approximately 20 have entered into a registry/ clinical study with Liventa.  

Read More


Tags: Dry Shipper, Frozen Shipping, Cold Chain Logistics, cold shipping, Liventa, Regenerative Medicine Point-of-Care Repository Sol, AmnioClear®

Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe

September 16, 2014

LAKE FOREST, CA – September 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the world’s leading provider of advanced cryogenic logistics solutions for the life-sciences industry, announced today that it has engaged Broekman Group, a global logistics company headquartered in Rotterdam, the Netherlands, to provide support to their rapidly expanding European client base. According to the terms of the agreement, Broekman’s European operations will support Cryoport’s leading-edge cryogenic logistics solutions throughout Europe.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Europe, Broekman Group

Cryoport Appoints VP of Strategic Business Development and Accelerates Expansion of Direct Sales Force

September 8, 2014

LAKE FOREST, CA – September 8, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, announced today the appointment of Curt Kole to the new role of VP, Strategic Business Development. Cryoport’s new business development personnel will support the Company’s rapid development and integration of large-scale corporate clients. In addition to securing new business sectors and major accounts for Cryoport, this new function will be responsible for the management of many key partnerships for the Company.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, sales, business development, Curt Kole, VP of Strategic Business Development

Cryoport to Present at the Aegis Healthcare & Technology Conference on September 12, 2014

September 2, 2014

LAKE FOREST, CA – September 2, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that its Chief Financial Officer, Robert Stefanovich, is scheduled to present at the Aegis Healthcare & Technology Conference on Friday, September 12, 2014 at 1:30 pm PT, at The Encore at Wynn Las Vegas.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Aegis Healthcare & Technology Conference

Cryoport Expands Sales Force to Meet Increasing Demand

August 12, 2014

LAKE FOREST, CA – August 12, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today the implementation of its sales force expansion program to accelerate the Company’s rapidly expanding customer base.  In addition to our key market sectors, the expanded sales team will provide direct support to our global integrator partners, who uniquely employ Cryoport’s ‘powered by Cryoport’ solutions into their respective strategies for the life sciences cold chain.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, sales, business development

Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015

July 31, 2014

LAKE FOREST, CA – July 31, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three month period ended June 30, 2014.  

Recent Operating Highlights

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Revenue, first quarter fiscal 2015

Cryoport and DHL Partner to Provide Cryogenic Logistics Solutions for Life Sciences and Healthcare Clients

July 16, 2014

LAKE FOREST, CA – July 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, partners with LifeConEx, a  part of DHL Global Forwarding, to enhance and supplement DHL’s cold chain logistics offerings including DHL Express’ Medical Express to its life sciences and healthcare customers with Cryoport’s comprehensive cryogenic logistics solutions.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, DHL